Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Angioedema With C1 Esterase Inhibitor Deficiency”

116 trials

Showing 20 of 116 results

Large-scale testing (Phase 3)Looking for participantsNCT07298447
What this trial is testing

Donidalorsen Treatment in Children With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Ionis Pharmaceuticals, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT01826916
What this trial is testing

EDEMA2: Evaluation of DX-88's Effect in Mitigating Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 77
Large-scale testing (Phase 3)Study completedNCT03472040
What this trial is testing

A Long Term Safety Study of BCX7353 in Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHAEProphylaxis
BioCryst Pharmaceuticals 387
Testing effectiveness (Phase 2)Study completedNCT01095497
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration

Who this might be right for
Hereditary Angioedema
Shire 26
Large-scale testing (Phase 3)Active Not RecruitingNCT05511922
What this trial is testing

PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 11
Not applicableStudy completedNCT05489640
What this trial is testing

A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 85
Not applicableStudy completedNCT05578417
What this trial is testing

Review the Treatment and Outcomes of Teenagers and Adults With Non-histaminergic Angioedema With Normal C1 Inhibitor in Canada

Who this might be right for
Hereditary Angioedema (HAE)Angioedema
Takeda 60
Large-scale testing (Phase 3)Enrolling By InvitationNCT07204938
What this trial is testing

A Long-Term Study of Navenibart in Participants With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Astria Therapeutics, Inc. 145
Not applicableStudy completedNCT05509569
What this trial is testing

A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 32
Not applicableUnknownNCT03828279
What this trial is testing

Global Registry to Gather Data on Natural History of Patients With Hereditary Angioedema Type I and II

Who this might be right for
Hereditary Angioedema Type I and II
HAE Global Registry Foundation 220
Large-scale testing (Phase 3)Looking for participantsNCT06679881
What this trial is testing

Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

Who this might be right for
Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V. 170
Large-scale testing (Phase 3)Active Not RecruitingNCT06634420
What this trial is testing

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
Intellia Therapeutics 60
Testing effectiveness (Phase 2)Ended earlyNCT04414631
What this trial is testing

Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Who this might be right for
Coronavirus Infections
University Hospital, Basel, Switzerland 80
Not applicableStudy completedNCT07009262
What this trial is testing

A Study Observing US Patients With HAE Type I or II Who Take Icatibant to Treat HAE Attacks

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 88
Testing effectiveness (Phase 2)Study completedNCT01095510
What this trial is testing

CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12

Who this might be right for
Hereditary Angioedema (HAE)
Shire 9
Testing effectiveness (Phase 2)Study completedNCT01576523
What this trial is testing

Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 18
Not applicableAvailableNCT06415448
What this trial is testing

Donidalorsen Expanded Access Program for Patients With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Ionis Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT02741596
What this trial is testing

Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Who this might be right for
Hereditary Angioedema (HAE)
Shire 212
Large-scale testing (Phase 3)Study completedNCT00912093
What this trial is testing

Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

Who this might be right for
Hereditary Angioedema
Shire 98
Not applicableStudy completedNCT04957641
What this trial is testing

The Burden of Illness and Treatment Patterns in Teenagers and Adults With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Takeda 221
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation